Whereas, once the tumor turns aggressive, tumor cells express immune checkpoint modulators [such as cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and programmed cell death 1 ligand 1 (PD-L1)] to suppress the immune response
Want to understand how GLP-1 receptor agonists work, the latest clinical research, and what to expect from treatment
Before using levocarnitine In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do
However, cases related to glucagon-like peptide-1 receptor agonists (GLP-1 RA) - have also been reported, particularly in the presence of additional risk factors such as a low-carbohydrate diet, nausea and vomiting leading to dehydration, gastrointestinal infections, or acute pancreatitis (13, 14)